Mariner, LLC Atossa Therapeutics, Inc. Transaction History

Mariner, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.74 - $1.35 $740 - $1,350	1,000 Added 0.95%	105,910 $78,000
Q1 2023 May 12, 2023	BUY	$0.59 - $0.91 $28 - $44	49 Added 0.05%	104,910 $76,000
Q3 2022 Nov 10, 2022	BUY	$0.82 - $1.14 $85,986 - $119,541	104,861 New	104,861 $87,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $185,377 - $378,865	-115,861 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $2,892 - $6,406	1,001 Added 0.87%	115,861 $378,000
Q2 2021 Aug 24, 2021	BUY	$1.52 - $8.62 $174,587 - $990,093	114,860 New	114,860 $726,000

29M

39.8K

90.9K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $109M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.